Document is current
Any future updates will be listed below
-
Authors
Panse, Jens https://orcid.org/0000-0001-6316-3112
Tölle, Daniela
Fiegle, Eva https://orcid.org/0000-0002-1639-5751
Naendrup, Jan-Hendrik https://orcid.org/0000-0002-6420-7938
Schmidt-Hieber, Martin https://orcid.org/0000-0002-3071-6945
Böll, Boris https://orcid.org/0000-0002-6432-0981
Hentrich, Marcus https://orcid.org/0000-0001-5622-348X
Teschner, Daniel https://orcid.org/0000-0001-7351-8060
Schalk, Enrico https://orcid.org/0000-0003-1892-5098
-
Funding
Funding for this research was provided by:
Otto-von-Guericke-Universität Magdeburg
- License Information
-
More Information
Article History
Received: 2 April 2022
Accepted: 13 August 2022
First Online: 17 August 2022
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. The SECRECY registry was approved by the central ethics committee (Magdeburg University Hospital, approval no. 84/14) as well as by respective local ethics committees.
: Given the nature of routine clinical data and the anonymization of patients’ data, written informed consent was not required within the study. However, written informed consent was mandatory for procedures during the clinical routine.
: The authors declare no competing interests.
: SECRECY (Study to Evaluate Central Venous Catheter-related Infections in Hematology and Oncology) was registered in the German Clinical Trial Register (DRKS; no. DRKS00006551).
